-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Darren Kocs, MD, MHSA

Articles by Darren Kocs, MD, MHSA

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

ByDarren Kocs, MD, MHSA,A. Mark Fendrick, MD

May 1st 2003

Latest Updated Articles

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
May 1st 2003

Trending on AJMC

Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices

Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures

IRA, 340B, Medicaid: The Policy Pressures on Community Oncology

PBM Satisfaction Stalls as Net Promoter Score Turns Negative

Drug Price Drives Value of MASH Therapies More Than Efficacy